NIBIB in the News

New research introduces a novel network analysis technology that uses minimally invasive resting state electrophysiological recordings to localize seizure onset brain regions and predict seizure outcomes in just 10 minutes. Source: Carnegie Mellon University

A collaborative team from the Terasaki Institute for Biomedical Innovation have developed a silk composite for significantly improved tendon regeneration and repair. Source: Science Daily

The value of MRI can be dramatically increased by making its output more quantitative so that images become maps of important tissue properties. To help achieve those goals, the National Institute of Standards and Technology’s Physical Measurement Laboratory (PML) in collaboration with NIBIB recently launched a unique service that provides MRI research centers and clinics with access to NIST-traceable reference standards. Source: NIST.

As race season approaches, many runners have the same goal: go faster. But researchers now show that speeding up might require defying our natural biology. By combining data from runners monitored in a lab along with 37,000 runs recorded on wearable fitness trackers, scientists have found that humans' natural tendency is to run at a speed that conserves caloric loss -- something that racers seeking to shave time off their miles will have to overcome. Source: Science Daily/Cell Press

Columbia engineering team demonstrates first multi-organ chip made of engineered human tissues linked by vascular flow for improved modeling of systemic diseases like cancer. Source: Columbia University

As the number of Covid-19 cases grows in the United States, experts wonder if the country fully understands the current threat from the pandemic. As the use of at-home Covid-19 tests rises, so does the concern that most of those test results go unreported, leading to an undercount of the true number of Covid-19 cases across the country. Source: CNN.com

An NIH-funded team at Cornell University has developed a compound delivered into the nose that blocked a protein used by SARS-CoV-2 to get into cells and prevented severe infection in mice. Antiviral drugs that target host cells may work against many existing and future variants of the virus that causes COVID-19. Source: NIH Research Matters

Researchers have discovered a molecular switch involved in controlling the transition from normal tissue repair to incomplete, or permanent, damage. The NIH-supported researchers also suggest a possible drug candidate to control this switch and slow the progression of chronic kidney disease. Source: NIH Director's Blog

Researchers in Atlanta have helped the federal government evaluate dozens of Covid tests and pioneer a new model for developing novel diagnostics. Source: The New York Times

Kaitlyn Sadtler, National Institute of Biomedical Imaging and Bioengineering, and Jamel Ali, Florida A&M University-Florida State University College of Engineering, have received a Grainger Grant for their project titled, “Evaluating the role of micro-mechanical remodeling during immune-mediating tissue regeneration.” The award to Florida A&M University, marks the first Grainger Grant to a Historically Black College and University. Source: National Academy of Engineering